Skip to content

Substance-focused SBI as a Complement to Internet-based Psychiatric Treatment: RCT

Substance-use Focused Screening and Brief Intervention as a Complement to Internet-based Psychiatric Treatment for Depression, Panic Disorder or Social Phobia: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01885026
Acronym
eScreeniPsy
Enrollment
93
Registered
2013-06-24
Start date
2013-07-31
Completion date
2016-01-31
Last updated
2018-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance Use Disorders (SUD)

Keywords

Randomized Controlled Trial, Alcohol, Drugs, Internet, Screening, Brief intervention

Brief summary

Objectives: This study evaluates the efficacy of eScreen for internet psychiatry patients treated for major depressive disorder, panic anxiety and social phobia. The eScreen brief Internet intervention for problematic alcohol and drug use offers self-screening, in-depth self-reporting, personalized feedback and treatment recommendations as well as an electronic diary. Progress over time is shown in diagrams detailing consumption levels. Method: This is a two-armed randomized controlled design, measuring outcomes in terms of changes in problematic alcohol use up to one year after study recruitment. Participants with problematic alcohol use (AUDIT \>7 for men and \>5 for women) and/or problematic drug use (DUDIT \> 1 for both men and women) are randomized into one of two groups: T1, eScreen referral or Control group. Outcomes on alcohol and drug use as well as health-related symptoms are assessed after 3, 6 and 12 months. The hypothesis is that the group receiving the eScreen intervention will reduce their alcohol/drug use to a larger extent than the control group at follow-up compared to the baseline level.

Detailed description

This study evaluated the efficacy of eScreen for internet psychiatry patients treated for major depressive disorder, panic anxiety and social phobia. The eScreen brief Internet intervention for problematic alcohol and drug use offers self-screening, in-depth self-reporting, personalized feedback and treatment recommendations as well as an electronic diary. Progress over time is shown in diagrams detailing consumption levels. The design was a two-armed randomized controlled design, measuring outcomes in terms of changes in problematic alcohol use up to one year after study recruitment. Participants with problematic alcohol use (AUDIT \>7 for men and \>5 for women) and/or problematic drug use (DUDIT \> 1 for both men and women) were randomized into one of two groups: T1, eScreen referral or Control group. Outcomes on alcohol and drug use as well as health-related symptoms are assessed after 3, 6 and 12 months. The hypothesis was that the group receiving the eScreen intervention would reduce their alcohol/drug use to a larger extent than the control group at follow-up compared to the baseline level. The results have not yet been analyzed due to technical issues. However, qualitative interviews have been conducted with participants and our intention is to publish the qualitative results in tandem with the quantitative results available.

Interventions

BEHAVIORALeScreen

Access to the eScreen platform offering assessment of alcohol and drug use, with automated feedback on problematic or non-problematic use. Follow-up over time based on user needs.

BEHAVIORALAssessment only of alcohol and drug use.

Assessment of alcohol and drug use at baseline and follow-up.

BEHAVIORALInternet-based treatment for depression or anxiety

Internet-based treatment for primary diagnoses of depression, panic anxiety or social phobia.

Sponsors

Karolinska Institutet
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
15 Years to No maximum
Healthy volunteers
No

Inclusion criteria

AUDIT \>7 for men and AUDIT \>5 for women, and/or DUDIT \>0

Exclusion criteria

DUDIT = 0 and AUDIT \<8 (men) or \<6 (women)

Design outcomes

Primary

MeasureTime frameDescription
Change in the total AUDIT-C score3, 6 and 12 monthsThe primary outcome measure for this trial is the change in the total AUDIT score for the first three AUDIT questions, as a measure of alcohol consumption only, referred to as the AUDIT-C.

Secondary

MeasureTime frameDescription
Alcohol Use Disorders Identification Test (AUDIT)3, 6 and 12 monthsChange in total AUDIT score, as a summarized measure of alcohol use (including alcohol consumption and alcohol-related problems).

Other

MeasureTime frameDescription
Changes in health parameters over time3, 6 and 12 monthsHealth-related questions on wellbeing, sleep, concentration, energy, social life, sadness and current life meaning, etc.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026